| 401/697 | US=25 / Urologia Zhou M, Magi-Galluzzi C. Pathologic implications of prostate biopsy. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 231-54. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. BIOPSIA DE PROSTATA; NEOPLASIA INTRAEPITELIAL PROSTATICA; PROLIFERACAO ACINAR ATIPICA; ATYP; ATROFIA |
| 402/697 | US=25 / Urologia Chang SS, Cookson MS. Complications of transrectal ultrasound-guided prostate biopsy. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 255-68. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. COMPLICACOES DA ULTRA-SONOGRAFIA TRANSRETAL BIOPSIA DE PROSTATA; BIOPSIA DA PROSTATA; COMPLICACOES; HEMATURIA; INFECCAO; RETENCAO URINARIA |
| 403/697 | US=25 / Urologia Weizer AZ, Gilbert SM, Shah RB, Wood Junior DP. Management and controversies of high-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on prostate biopsy. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 269-86. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. CONTROVERSIAS DE ALTO GRAU DE NEOPLASIA INTRAEPITELIAL PROSTATICA PROLIFERACAO ACINAR ATIPICA DE BIOPSIA DE PROSTATA; NEOPLASIA INTRAEPITELIAL PROSTATICA; PROLIFERACAO ACINAR ATIPICA |
| 404/697 | US=25 / Urologia Fitzsimons NJ, Bañez LL, Sun LL, Moul JW. Future directions in prostate cancer diagnosis. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 287-312. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. DIAGNOSTICO DE CANCER DE PROSTATA; CANCER DE PROSTATA; BLINDAGEM; PSA; BIOIMAGING BIOMARCADOR |
| 405/697 | US=25 / Urologia Loeb S, Han M, Catalona WJ. Prostate-specific antigen and prostate cancer screening. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 15-27. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. ANTIGENIO ESPECIFICO DA PROSTATA; EXAMES DE CANCER DE PROSTATA; PSA; PERCENTAGEM DE PSA LIVRE; DENSIDADE DO PSA; VELOCIDADE DO PSA |
| 406/697 | US=35 / Biol/Mol Greene KL, Li LC, Okino ST, Carroll PR. Molecular basis of prostate cancer. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 431-40. ISBN 978-1-4160-3703-3. CANCER DE PROSTATA; BIOLOGIA MOLECULAR; GRAU DE GLEASON; NEOPLASIA INTRAEPITELIAL PROSTATICA DE ALTO GRAU; PATOLOGIA MOLECULAR; MICRO-RNA |
| 407/697 | US=23-A / Câncer Gwyther SJ. Detection of recurrent cancer by radiological imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 17-37. ISBN 978-1-4020-8441-62. CANCER. DIAGNOSTICO; IMAGEM; RADIOLOGIA; CANCER DE PULMAO; CANCER DE MAMA; CANCER COLORRETAL; LINFOMA; CANCER PANCREATICO; CANCER DE PROSTATA; CANCER DE ESOFAGO; CANCER DE OVARIO; CANCER DE ENDOMETRIO; CANCER CERVICAL; CANCER DE CABECA E PESCOCO; CANCER DE TIREOIDE; TUMORES INTRACRANIANOS PRIMARIO |
| 408/697 | US=35 / Estatística Rushton G, Cai Q, Chen Z. Producing spatially continuous prostate cancer maps with different geocodes and spatial filter methods. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 69-90. ISBN 0-8493-8419-2. PRODUTORAS DE MAPAS ESPACIALMENTE CANCER DE PROSTATA; GEOCODES DIFERENTES; MAPAS DE CANCER; TAXAS DE MORTALIDADE CANCER DE PROSTATA |
| 409/697 | US=23-A / Câncer Hayat MA. Prostate carcinoma. In: ___. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 391-6. ISBN 978-1-4020-8441-62. |
| 410/697 | US=23-A / Câncer Franklin RB, Costello LC. The role of intermediary metabolism and molecular genetics in prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 397-413. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; METABOLISMO INTERMEDIARIO; GENETICA MOLECULAR; CITRATO; M-ACONITASE; ZINCO; GLUCOSE; ASPARTATO; OXALACETATO; BIOENERGETICOS; LIPOGENESE |
| 411/697 | US=23-A / Câncer Ribeiro FR, Skotheim RI, Henrique R, Teixeira MR. Array-based comparative genomic hybridization in prostate cancer: research and clinical applications. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 415-29. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; HIBRIDIZACAO GENOMICA COMPARATIVA |
| 412/697 | US=23-A / Câncer Lu S. Prostate cancer: role of Vav3 overexpression in development and progression. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 431-9. ISBN 978-1-4020-8441-62. |
| 413/697 | US=23-A / Câncer Dakubo GD, Parr RL, Jakupciak JP. Prostate cancer: detection and monitoring using mitochondrial mutations as a biomarker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 441-64. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; CANCER DE PROSTATA. DIAGNOSTICO; MUTACAO MITOCONDRIAL; BIOMARCADOR; GENETICA MITOCONDRIAL; BIOENERGETICA MITOCONDRIAL; ONCOLOGIA; METABOLISMO CELULAR; MUTACAO DE DNA |
| 414/697 | US=23-A / Câncer El-Sharkawy SL, Abbas NF, El-Hefnawy NG. Prognostic markers in prostatic carcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 465-79. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; MARCADORES PROGNOSTICOS; CARCINOMA DA PROSTATA |
| 415/697 | US=23-A / Câncer Schwarzenbach H, Pantel K. Prostate cancer: detection of free tumor-specific DNA in blood and bone marrow. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 481-97. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; DNA; SANGUE; MEDULA OSSEA; GENETICA; EPIGENETICA; CELULAS DE ACIDOS NUCLEICOS; PLASMA; ANALISE DE MICROSSATELITES; POLIMORFISMOS DE UM UNICO NUCLEOTIDEO; PCR BASEADA FLUORESCENCIA |
| 416/697 | US=23-A / Câncer Turgut AT, Dogra VS. Prostate carcinoma: evaluation using transrectal sonography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 499-520. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; CARCINOMA DA PROSTATA; ULTRA-SONOGRAFIA TRANSRETAL; DOPPLER COLORIDO; ULTRA-SONOGRAFIA COM CONTRASTE; ELASTOGRAFIA |
| 417/697 | US=23-A / Câncer Zanzonico P. Prostate cancer: 16B-[18F] Fluoro-5x-Dihydrotesterone (FDHT) whole-body positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 521-30. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; 16B-[18F] FLUORO-5X-DIHYDROTESTERONE (FDHT); TOMOGRAFIA POR EMISSAO DE POSITRONS; RECEPTOR DE ANDROGENO |
| 418/697 | US=23-A / Câncer Nesslinger NJ, Pai HH, Ludgate CM, Nelson BH. Effects of standard treatments on the immune response to prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 531-55. ISBN 978-1-4020-8441-62. |
| 419/697 | US=23-A / Câncer Kalakish S, Torti FM. Vinorelbine, Doxorubicin, and Prednisone in hormone refractory prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 557-64. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; VINORELBINA; DOXORUBICINA; PREDNISONA |
| 420/697 | US=23-A / Câncer Crook J. Locally advanced protate cancer biochemical recurrence after radiotherapy: use of cyclic androgen withdrawal therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 565-77. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; RECORRENCIA LOCALMENTE AVANCADO; BIOQUIMICA; RADIOTERAPIA; TERAPIA CICLICA; ANDROGENO |